Design, synthesis, biological evaluation and computational investigation of Thiadiazole Benzimidazole derivatives bearing a Chlorophyrimidine pharmacophore as potent CLK2 inhibitors and anticancer agents
Bioorganic Chemistry · 2026-11 · 183 · 110618
DOI: 10.1016/j.bioorg.2026.110618 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioorganic Chemistry, 2026-11. Verfasst von Tariq Aziz und 7 weiteren Autor:innen. Beteiligte Einrichtung: Molecular Microbiology and Infectious Diseases Research Unit, University of Tabuk, 71491 Tabuk, Saudi Arabia. Electronic address: tariqckd@ut.edu.sa. Hauptthemen laut MEDLINE: Antineoplastic Agents, Drug Design, Thiadiazoles, Benzimidazoles. Die Arbeit nennt 36 Literaturangaben. Gefördert von: Princess Nourah bint Abdulrahman University.
Abstract (Originalsprache)
Cdc2-like kinase 2 (CLK2) has emerged as an attractive anticancer therapeutic target because of its crucial role in pre-mRNA splicing and tumor growth. Here, we designed and synthesized a novel series of thiadiazole-based benzimidazole derivatives 15a-l incorporating chloropyrimidine pharmacophore and evaluated for CLK2 inhibition and antiproliferative activity against HCT116 cells. The synthesized derivatives exhibited CLK2 inhibition potential ranged from 0.2332 nM to >50 nM, with 15i displaying the highest potency with IC50 of 0.2332 nM, followed by 15 l (0.3342 nM), 15 k (0.5648 nM), and 15 g (0.6453 nM), as compared to standard T-025 (IC50 = 1.0 nM). In antiproliferative assay, 15 l exhibited the highest activity against HCT116 cells with IC50 23.52 nM, followed by compounds 15 h (28.54 nM), 15i (29.17 nM), and 15 g (33.43 nM), demonstrating higher cellular potency than T-025 (IC50 = 42 nM). Structure activity relationship (SAR) analysis indicated that fluorinated aromatic substituents and certain heteroaryl moieties linked to a thiadiazole ring favored CLK2 inhibition, although biochemical and cellular activities were not directly proportional. Molecular docking and molecular dynamics simulations provided a structural rationale consistent with experimental results by revealing the favorable and stable binding interactions within the CLK2 ATP-binding pocket. Density functional theory (DFT) calculations and in silico ADMET predictions further supported favorable electronic properties, drug-likeness and low predicted toxicity of the synthesized compounds.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Molecular Microbiology and Infectious Diseases Research Unit, University of Tabuk, 71491 Tabuk, Saudi Arabia. Electronic address: tariqckd@ut.edu.sa.
- College of Biology, Hunan University Changsha, Hunan 410082, China. Electronic address: rafaqathussain0347@gmail.com.
- Department of Chemistry, Quaid-i-Azam University, Islamabad 45320, Pakistan.
- Department of Pharmacy, Forman Christian College University Lahore.
- Department of Pharmacy Practice, College of Pharmacy, Princess Nourah bint Abdulrahman University, P.O.Box 84428, Riyadh 11671, Saudi Arabia.
- Department of Biology, College of Science, Princess Nourah bint Abdulrahman University, P.O.Box 84428, Riyadh 11671, Saudi Arabia.
Förderung
- Princess Nourah bint Abdulrahman University
Zitieren
APA
Aziz, T., Hussain, R., Sarfraz, H., Azam, U., Asjad, M. M., Binsaleh, A. Y., Al-Hoshani, N., & Mojally, M. (2026). Design, synthesis, biological evaluation and computational investigation of Thiadiazole Benzimidazole derivatives bearing a Chlorophyrimidine pharmacophore as potent CLK2 inhibitors and anticancer agents. Bioorganic Chemistry, 183, 110618. https://doi.org/10.1016/j.bioorg.2026.110618
Vancouver
Aziz T, Hussain R, Sarfraz H, Azam U, Asjad MM, Binsaleh AY, et al. Design, synthesis, biological evaluation and computational investigation of Thiadiazole Benzimidazole derivatives bearing a Chlorophyrimidine pharmacophore as potent CLK2 inhibitors and anticancer agents. Bioorganic Chemistry. 2026;183:110618. doi:10.1016/j.bioorg.2026.110618
BibTeX
@article{Aziz2026,
author = {Aziz, Tariq and Hussain, Rafaqat and Sarfraz, Hina and Azam, Uzam and Asjad, Muhammad Mazhar and Binsaleh, Ammena Y and Al-Hoshani, Nawal and Mojally, Mariam},
title = {Design, synthesis, biological evaluation and computational investigation of Thiadiazole Benzimidazole derivatives bearing a Chlorophyrimidine pharmacophore as potent CLK2 inhibitors and anticancer agents},
journal = {Bioorganic Chemistry},
year = {2026},
volume = {183},
pages = {110618},
doi = {10.1016/j.bioorg.2026.110618}
}
EUVIMED